About
Cardiovascular treatments
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Team (25)
Adam Koppel
Adam Koppel, M.D., Ph.D., MBAManaging Director,Bain Capital Life Sciences
Cardurion Pharmaceuticals
team_member
Charlotte Newman
Charlotte NewmanChief Business Officer
Cardurion Pharmaceuticals
team_member
Dan Lynch
Dan LynchExecutive VenturePartner, GV
Cardurion Pharmaceuticals
team_member
David Kass
David Kass, M.D.Professor of Medicine and Cardiology, John Hopkins University School of Medicine
Cardurion Pharmaceuticals
team_member
Douglas Mann
Douglas Mann, M.D.Professor of Medicine and Cardiology, Washington University School of Medicine
Cardurion Pharmaceuticals
team_member
Ed Mathers
Ed MathersPartner, NEA
Cardurion Pharmaceuticals
team_member
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
11
As Collaborator
5
Total Enrollment
1,660
By Phase
PHASE2: 11PHASE1: 3NA: 1PHASE1/PHASE2: 1
By Status
COMPLETED: 9TERMINATED: 4NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06658899Lead Sponsor
A Phase 2 Study of CRD-4730 in CPVT
PHASE2Not yet recruiting
12 participants
Started: Dec 31, 2025 · Completed: Apr 30, 2027
NCT06215586Lead Sponsor
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
PHASE2Completed
303 participants
Started: Feb 13, 2024 · Completed: Sep 2, 2025
NCT06215911Lead Sponsor
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
PHASE2Active, not recruiting
557 participants
Started: Feb 13, 2024 · Completed: Oct 31, 2025
NCT06005428Lead Sponsor
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
PHASE2Terminated
7 participants
Started: Nov 7, 2023 · Completed: May 31, 2025
NCT05437094Lead Sponsor
Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740
PHASE1Completed
20 participants
Started: Jun 27, 2022 · Completed: Aug 10, 2022
Locations (1)
Headquarters
Burlington, MA, United States
Map
Loading map...